Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Genome-Wide Search for Nonadditive Allele Effects Identifies PSKH2 as Involved in the Variability of Factor V Activity

  • Gendre, B.
  • Martinez-Perez, Angel|||0000-0002-5934-1454
  • Vlieg, A.v.H.|||0000-0001-7386-1168
  • Boland, Anne|||0000-0001-8789-5676
  • Germain, M.|||0000-0002-8489-8916
  • Munsch, G.|||0000-0003-1564-9825
  • Moissl, Angela Patricia|||0000-0003-0302-2136
  • Suchon, P.
  • Souto, Juan Carlos|||0000-0003-2092-5142
  • Soria Fernández, José Manuel|||0000-0002-6226-4293
  • Deleuze, J.F.|||0000-0002-5358-4463
  • Rosendaal, Frits|||0000-0003-2558-7496
  • Sabater-Lleal, Maria|||0000-0002-0128-379X
  • Morange, Pierre-Emmanuel|||0000-0002-9065-722X
  • Trégouët, David-Alexandre|||0000-0001-9084-7800
  • Kleber, M.E.
  • Olaso, R.
  • März, W.
BACKGROUND: Factor V (FV) is a key molecular player in the coagulation cascade. FV plasma levels have been associated with several human diseases, including thrombosis, bleeding, and diabetic complications. So far, 2 genes have been robustly found through genome-wide association analyses to contribute to the inter-individual variability of plasma FV levels: structural F5 gene and PLXDC2. METHODS AND RESULTS: The authors used the underestimated Brown-Forsythe methodology implemented in the QuickTest software to search for non-additive genetic effects that could contribute to the inter-individual variability of FV plasma activity. QUICKTEST was applied to 4 independent genome-wide association studies studies (LURIC [Ludwigshafen RIsk and Cardiovascular Health Study], MARTHA [Marseille Thrombosis Association], MEGA [Multiple Environmental and Genetic Assessment], and RETROVE [Riesgo de Enfermedad Tromboembolica Venosa]) totaling 4505 participants of European ancestry with measured FV plasma levels. Results obtained in the 4 cohorts were meta-analyzed using a fixed-effect model. Additional analyses involved exploring haplotype and gene×gene interactions in downstream investigations. A genome-wide significant signal at the PSKH2 locus on chr8q21.3 with lead variant rs75463553 with no evidence for heterogeneity across cohorts was observed (P=0.518). Although rs75463553 did not show an association with mean FV levels (P=0.49), it demonstrated a robust significant (P=3.38x10) association with the variance of FV plasma levels. Further analyses confirmed the reported association of PSKH2 with neutrophil biology and revealed that rs75463553 likely interacts with two loci, GRIN2A and POM121L12, known for their involvement in smoking biology. CONCLUSIONS: This comprehensive approach identifies the role of PSKH2 as a novel molecular player in the genetic regulation of FV, shedding light on the contribution of neutrophils to FV biology.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Next generation sequencing to dissect the genetic architecture of KNG1 and F11 loci using factor XI levels as an intermediate phenotype of thrombosis

  • Martin-Fernandez, Laura|||0000-0002-8909-508X
  • Gavidia-Bovadilla, Giovana
  • Corrales Insa, Irene|||0000-0002-0647-0340
  • Brunel, Helena|||0000-0002-1036-7928
  • Ramírez, Lorena
  • López, Sonia|||0000-0002-5023-5153
  • Souto, Juan Carlos|||0000-0003-2092-5142
  • Vidal, Francisco|||0000-0001-8089-4945
  • Soria Fernández, José Manuel|||0000-0002-6226-4293
Venous thromboembolism is a complex disease with a high heritability. There are significant associations among Factor XI (FXI) levels and SNPs in the KNG1 and F11 loci. Our aim was to identify the genetic variation of KNG1 and F11 that might account for the variability of FXI levels. The KNG1 and F11 loci were sequenced completely in 110 unrelated individuals from the GAIT-2 (Genetic Analysis of Idiopathic Thrombophilia 2) Project using Next Generation Sequencing on an Illumina MiSeq. The GAIT-2 Project is a study of 935 individuals in 35 extended Spanish families selected through a proband with idiopathic thrombophilia. Among the 110 individuals, a subset of 40 individuals was chosen as a discovery sample for identifying variants. A total of 762 genetic variants were detected. Several significant associations were established among common variants and low-frequency variants sets in KNG1 and F11 with FXI levels using the PLINK and SKAT packages. Among these associations, those of rs710446 and five low-frequency variant sets in KNG1 with FXI level variation were significant after multiple testing correction and permutation. Also, two putative pathogenic mutations related to high and low FXI levels were identified by data filtering and in silico predictions. This study of KNG1 and F11 loci should help to understand the connection between genotypic variation and variation in FXI levels. The functional genetic variants should be useful as markers of thromboembolic risk.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

TMAO and Gut Microbial-Derived Metabolites TML and γBB Are Not Associated with Thrombotic Risk in Patients with Venous Thromboembolism

  • Canyelles, Marina|||0000-0002-0278-5337
  • Plaza, Melania|||0000-0002-1471-3672
  • Rotllan, Noemi|||0000-0002-0587-8045
  • Llobet, Dolors
  • Julve i Gil, Josep|||0000-0002-6531-2246
  • Mojal, Sergi|||0000-0003-0523-3869
  • Diaz-Ricart, Maribel|||0000-0003-1122-0052
  • Soria Fernández, José Manuel|||0000-0002-6226-4293
  • Escolà-Gil, Joan Carles|||0000-0001-9021-2485
  • Tondo Colomer, Mireia|||0000-0002-0301-9984
  • Blanco Vaca, Francisco|||0000-0001-7380-5385
  • Souto, Juan Carlos|||0000-0003-2092-5142
Background: The present work evaluates the association between circulating concentrations of Trimethylamine-N-oxide (TMAO), gamma butyrobetaine (γBB), and trimetyllisine (TML) in controls and patients with venous thromboembolism (VTE) with coagulation parameters. Methods: The study involved 54 VTE patients and 57 controls. Platelet function, platelet hyperreactivity, platelet adhesiveness, thrombosis-associated parameters, and thrombin generation parameters were studied. Plasma TMAO, γBB, and TML determination was performed using an ultra-high-performance liquid chromatography system coupled with mass spectrometry. Results: No differences were found for TMAO, γBB, or TML concentrations between controls and VTE patients. In thrombin generation tests, TMAO, γBB, and TML showed a positive correlation with lag time and time to peak. TMAO, γBB, and TML negatively correlated with peak height. No significant differences were observed regarding TMAO, γBB, and TML concentrations between the two blood withdrawals, nor when the control and VTE patients were analyzed separately. No correlation was observed between these gut metabolites and platelet function parameters. Conclusions: No differences were found regarding TMAO, γBB, and TML concentrations between the control and VTE groups. Some correlations were found; however, they were mild or went in the opposite direction of what would be expected if TMAO and its derivatives were related to VTE risk.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Polygenic risk of major depressive disorder as a risk factor for venous thromboembolism

  • Ward, Joey
  • Le, Ngoc-Quynh
  • Suryakant, Suryakant
  • Brody, Jennifer A.|||0000-0001-8509-148X
  • Amouyel, Philippe|||0000-0001-9088-234X
  • Boland, Anne|||0000-0001-8789-5676
  • Bown, Rosemary|||0000-0002-1719-2761
  • Cullen, Breda Mary
  • Debette, Stéphanie|||0000-0001-8675-7968
  • Deleuze, Jean François
  • Emmerich, Joseph D.
  • Graham, Nicholas A.
  • Germain, Marine
  • Anderson, Jana|||0000-0001-7290-6635
  • Pell, Jill P.
  • Lyall, Donald M.
  • Lyall, Laura|||0000-0001-7216-1434
  • Smith, Daniel J.
  • Wiggins, Kerri L.|||0000-0003-2749-1279
  • Soria Fernández, José Manuel|||0000-0002-6226-4293
  • Souto, Juan Carlos|||0000-0003-2092-5142
  • Morange, Pierre-Emmanuel|||0000-0002-9065-722X
  • Smith, Nicholas L.|||0000-0003-3483-353X
  • Trégouët, David-Alexandre|||0000-0001-9084-7800
  • Sabater-Lleal, Maria|||0000-0002-0128-379X
  • Strawbridge, Rona J.|||0000-0001-8506-3585
Major depressive disorder (MDD), bipolar disorder (BD), and schizophrenia (SCZ) are associated with an increased risk of cardiovascular diseases, including venous thromboembolism (VTE). The reasons for this are complex and include obesity, smoking, and use of hormones and psychotropic medications. Genetic studies have increasingly provided evidence of the shared genetic risk of psychiatric and cardiometabolic illnesses. This study aimed to determine whether a genetic predisposition to MDD, BD, or SCZ is associated with an increased risk of VTE. Genetic correlations using the largest genome-wide genetic meta-analyses summary statistics for MDD, BD, and SCZ (Psychiatric Genetics Consortium) and a recent genome-wide genetic meta-analysis of VTE (INVENT Consortium) demonstrated a positive association between VTE and MDD but not BD or SCZ. The same summary statistics were used to construct polygenic risk scores for MDD, BD, and SCZ in UK Biobank participants of self-reported White British ancestry. These were assessed for impact on self-reported VTE risk (10 786 cases, 285 124 controls), using logistic regression, in sex-specific and sex-combined analyses. We identified significant positive associations between polygenic risk for MDD and the risk of VTE in men, women, and sex-combined analyses, independent of the known risk factors. Secondary analyses demonstrated that this association was not driven by those with lifetime experience of mental illness. Meta-analyses of individual data from 6 additional independent cohorts replicated the.